Clinical Trial Update: Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rifabutin to rifampicin for treatment of prosthetic joint infection treated with DAIR, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection

Drugs mentioned

• RIFABUTIN (Rifabutin)
• Rifampicin

Snippet

Sponsor: Tourcoing Hospital | Conditions: Prosthetic Infection | Phase 3 | Status: RECRUITING